Vimarsana
Biggest News Aggregation in the World

Page 4 - Jack Cox News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jack Cox. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jack Cox Today - Breaking & Trending Today

Eisai: "LEQEMBI" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in China -January 09, 2024 at 10:22 pm EST - Vimarsana News

Eisai: "LEQEMBI" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in China -January 09, 2024 at 10:22 pm EST

- Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti- soluble aggregated amyloid-beta monoclonal antibody LEQEMBI has been approved in China as a treatment of mild cognitive...

Will More Housing Options Destroy Dallas Single-Family Neighborhoods? - Vimarsana News

Will More Housing Options Destroy Dallas Single-Family Neighborhoods?

City Council members and residents turned out yesterday to oppose the building of duplexes, triplexes and fourplexes near single family homes.

ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for Women with Postpartum Depression (PPD), is - Vimarsana News

ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for Women with Postpartum Depression (PPD), is

ZURZUVAE, the first and only oral, once-daily, 14-day treatment course, has shown to provide rapid improvements in depressive symptoms at Day 15 and as early as Day 3 for women with PPDPatient support program, ZURZUVAE For You, and financial assistance available to eligible women with PPD prescribed ZURZUVAEPatients...

Biogen : "LEQEMBI® Intravenous Infusion" (Lecanemab) for the Treatment of Alzheimer's Disease to be Launched in Japan on December 20 -December 12, 2023 at 09:19 pm EST - Vimarsana News

Biogen : "LEQEMBI® Intravenous Infusion" (Lecanemab) for the Treatment of Alzheimer's Disease to be Launched in Japan on December 20 -December 12, 2023 at 09:19 pm EST

TOKYO and CAMBRIDGE, Mass., December 12, 2023 - Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti- soluble aggregated amyloid-beta monoclonal antibody LEQEMBI®...

Biogen Appoints Monish Patolawala to its Board of Directors - Vimarsana News

Biogen Appoints Monish Patolawala to its Board of Directors

Accomplished executive brings deep expertise leading global financial organizations and overseeing successful business transformationCAMBRIDGE, Mass., Nov. 06, 2023 -- Biogen Inc. today announced...